Literature DB >> 6498805

Gossypol inhibits Ehrlich ascites tumor cell proliferation.

W W Tso.   

Abstract

Neutral gossypol solution injected peritoneally into NMRI mice preimplanted with Ehrlich ascites tumour cell, at a dose of 25-100 micrograms/mouse per day, lengthened the number of survival days of the hosts. This gossypol effect on tumour cell proliferation is concentration dependent. The optimum dose is 100 micrograms. However, at too high a dose, the gossypol caused a body weight loss and the death of the tumour-bearing mice.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498805     DOI: 10.1016/0304-3835(84)90021-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

Review 1.  An overview of the clinical pharmacology and therapeutic potential of gossypol as a male contraceptive agent and in gynaecological disease.

Authors:  D Wu
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

2.  Developing gossypol derivatives with enhanced antitumor activity.

Authors:  X S Liang; A J Rogers; C L Webber; T J Ormsby; M E Tiritan; S A Matlin; C C Benz
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

3.  Antitumor effects of gossypol on murine tumors.

Authors:  P N Rao; Y C Wang; E Lotzova; A A Khan; S P Rao; L C Stephens
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

4.  A preliminary clinical study of gossypol in advanced human cancer.

Authors:  R C Stein; A E Joseph; S A Matlin; D C Cunningham; H T Ford; R C Coombes
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines.

Authors:  T Coyle; S Levante; M Shetler; J Winfield
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Cytotoxicity of enantiomers of gossypol.

Authors:  A E Joseph; S A Matlin; P Knox
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.